Cite
HARVARD Citation
Harrison, S. et al. (2022). Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet gastroenterology and hepatology. pp. 603-616. [Online].